Pfizer Inc. recalls diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1),
Recalled January 10, 2018 · FDA recall D-0150-2018 · Pfizer
Hazard
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent · FDA Class I
Units
183437 bottles
Sold at
Nationwide in the USA
Description
SUPERPOTENT: Weight variations resulting in tablets that are sub and super potent
Product
diphenoxylate hydrochloride and atropine sulfate tablets, USP, 2.5 mg/0.025 mg, a) 100-count bottle (NDC 59762-1061-1), b) 1000-count bottle (NDC 59762-1061-2), Rx Only, Distributed by: Greenstone LLC. Peapack, NJ 07977
Manufacturer(s)
Pfizer Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →